Nonbone Marrow CD34+Cells Are Crucial for Endothelial Repair of Injured Artery

Liujun Jiang,Ting Chen,Shasha Sun,Ruilin Wang,Jiacheng Deng,Lingxia Lyu,Hong Wu,Mei Yang,Xiangyuan Pu,Luping Du,Qishan Chen,Yanhua Hu,Xiaosheng Hu,Yijiang Zhou,Qingbo Xu,Li Zhang
DOI: https://doi.org/10.1161/circresaha.121.319494
IF: 23.213
2021-01-01
Circulation Research
Abstract:Rationale:Endothelial cells play a critical role in multiple cardiovascular diseases. Circulating CD34+cells are believed to be endothelial progenitors that have been used to treat cardiovascular diseases. However, the exact identity and the role of CD34+cells in vascular regeneration remains unclear.Objective:We aimed to investigate the exact identity and the role of CD34+cells in vascular regeneration.Methods and Results:Compared with healthy arteries, CD34 expression percentage was significantly increased in diseased femoral arteries from patients. Using a guidewire-induced endothelial denudation model, we reported the transcriptional profiling of over 30 000 cells by single-cell RNA sequencing analysis and provided a cell atlas of normal and lesioned arteries in mouse, in which a heterogeneous population of CD34+cells was revealed. Combining the inducible lineage tracingCd34-CreERT2;R26-tdTomato mouse model and bone marrow transplantation experiments, we showed that nonbone marrow CD34+mesenchymal cells acquired endothelial cell fate in the injured femoral artery rather than preexiting endothelial cells, while bone marrow-derived CD34+cells differentiated into immune cells locally after vessel injury. Depletion of nonbone marrow CD34+cells using diphtheria toxin-induced cell ablation models exacerbate neointimal lesions of the injured vessel. Furthermore, isolated vascular adventitia CD34+cells displayed endothelial differentiation, in which microRNA-21-Smad7-pSmad2/3 pathway regulated endothelial gene expression and function during differentiation.Conclusions:Our study provides a transcriptional and cellular landscape of vessels after endothelial denudation. Our findings suggest heterogeneous CD34+cells serve as a contributor not only to endothelial regeneration but also an inflammatory response that may provide therapeutic insights into vascular diseases.
What problem does this paper attempt to address?